Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks

Human immunodeficiency virus type 1 (HIV-1) infection is treated with antiretroviral therapy (ART), usually consisting of 2–3 different drugs, referred to as combination ART (cART). Our recent randomized clinical trial comparing a switch to dolutegravir monotherapy with continuation of cART in early...

Descripción completa

Detalles Bibliográficos
Autores principales: Jörimann, Lisa, Tschumi, Jasmin, Zeeb, Marius, Leemann, Christine, Schenkel, Corinne D, Neumann, Kathrin, Chaudron, Sandra E, Zaheri, Maryam, Frischknecht, Paul, Neuner-Jehle, Nadia, Kuster, Herbert, Braun, Dominique L, Grube, Christina, Kouyos, Roger, Metzner, Karin J, Günthard, Huldrych F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547464/
https://www.ncbi.nlm.nih.gov/pubmed/37498738
http://dx.doi.org/10.1093/infdis/jiad292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547464/
https://www.ncbi.nlm.nih.gov/pubmed/37498738
http://dx.doi.org/10.1093/infdis/jiad292

Ejemplares similares